Sonoma Pharmaceuticals
SNOA
13 hedge funds and large institutions have $456K invested in Sonoma Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.05% less ownership
Funds ownership: 6.01% → 5.96% (-0.05%)
20% less capital inflows, than outflows
Capital inflows: $47.6K | Capital outflows: $59.3K
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Liberty Wealth Management
Oakland,
California
|
-$33K |
| 2 |
Bard Associates
Chicago,
Illinois
|
-$16K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.3K |
SNOA Hedge Fund Activity: Q3 2019 in Review
13 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2019, worth a combined $456K — down 28% from $631K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SNOA and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $47.6K. The largest seller was Liberty Wealth Management, exiting entirely with an estimated $33K sold.
- 13 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $456K of Sonoma Pharmaceuticals stock for Q3 2019, down 28% quarter-over-quarter.
- 1 fund opened new Sonoma Pharmaceuticals positions in Q3 2019 and 2 closed out, a net change of -1 holder.
- The largest Sonoma Pharmaceuticals buyer in Q3 2019 was Renaissance Technologies, an estimated $47.6K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2019 was Liberty Wealth Management, an estimated $33K sold.
Based on aggregated 13F filings for Q3 2019.